Trump comments tied to reduced Tylenol use in pregnancy and surge in leucovorin prescriptions, The Lancet study says
After the White House briefing, Tylenol orders for pregnant women dropped 10%, while leucovorin prescriptions for children with autism rose 71% nationwide, per a Lancet study.
- Comments by Donald Trump warning pregnant women against taking Tylenol were followed by a 10% drop in prescriptions of its active ingredient, paracetamol, for pregnant patients visiting emergency departments, according to research published in The Lancet.
- Trump had said the Food and Drug Administration would caution doctors about a possible link between Tylenol use during pregnancy and autism, though current scientific evidence has not confirmed such a connection.
- Researchers from Harvard Medical School and Brown University found the decline likely reflects changes in patient behavior, with pregnant women potentially refusing the medication after the remarks.
- The study also found a 71% rise in prescriptions for the drug leucovorin in children, after Trump suggested it could help with autism symptoms, highlighting how public statements can significantly influence medical decisions.
101 Articles
101 Articles
Tylenol use among women dropped after Trump tied it to autism
Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S. emergency room prescribing patterns published in the UK medical journal Lancet. In September, Trump said pregnant women should avoid using Tylenol, the brand name for the product known as acetaminophen or paracetamol owned by Kenvue. Health officials cited research claiming prenatal …
Tylenol Orders Down, Leucovorin Scripts Up After Trump's Unproven Claims
(MedPage Today) -- Acetaminophen (Tylenol) orders for pregnant women during emergency department (ED) encounters and leucovorin (Wellcovorin) prescriptions in outpatient clinics underwent notable shifts after a White House briefing last fall that...
Study tracks surge in leucovorin after White House promotion
A White House briefing in September 2025 that raised concerns about acetaminophen use during pregnancy and promoted the drug leucovorin as a potential autism treatment was followed by sharp changes in how doctors prescribed those medications nationwide, according to a new study.
Tylenol Use Drops Among Some Pregnant Women After Trump's Unproven Autism Claim
Last year, President Donald Trump promoted unproven ties between Tylenol and autism and touted an old generic drug as a treatment for the developmental condition Tylenol Use Drops Among Some Pregnant Women After Trump's Unproven Autism Claim.
Study suggests Trump’s unproven claims that Tylenol causes autism influenced care
Last year, President Donald Trump told pregnant women not to take Tylenol as he promoted unproven ties between the fever reducer and autism and touted an old generic drug as a treatment for the developmental condition.
Study suggests Trump’s unproven autism claims influenced care
By LAURA UNGAR Last year, President Donald Trump told pregnant women not to take Tylenol as he promoted unproven ties between the fever reducer and autism and touted an old generic drug as a treatment for the developmental condition. Related Articles Trump turns to an Oklahoma senator with a fighter’s reputation as his next choice to lead DHS Man pleads guilty to bringing explosives to a DC church marking the start…
Coverage Details
Bias Distribution
- 66% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

























